SNAP-8 Dosage Protocol
An acetyl octapeptide-3 SNARE complex modulator for topical expression line reduction -a cosmetic botulinum toxin alternative. Complete application guide and peer-reviewed references.
Dosing & Administration Guide
SNAP-8 is supplied as a pre-mixed solution and does not require reconstitution. Follow the titration schedule below.
| Phase | Daily dose | U-100 units | Injection volume |
|---|---|---|---|
| Standard | 5–10% concentration | Topical application | Per formulation |
Route: Topical ONLY · Frequency: 1–2× daily topical · Cycle: Ongoing
Supplies Needed
Estimates below assume the titration schedule listed above.
Storage Instructions
Allow refrigerated vials to reach room temperature before opening to minimize condensation uptake. Always inspect for cloudiness or particulates before use -discard if present.
Looking for research-grade peptides? Pacific Edge Labs carries a growing catalog of high-purity compounds with third-party lab results published on each product page.
Why Pacific Edge Labs
- High-purity compounds with third-party lab results available on the website
- Consistent quality control with ISO-aligned handling and documentation
- Fast, discreet shipping with proper handling and packaging
SNAP-8 is not currently in the PEL catalog -check back for availability.
How SNAP-8 Works
SNAP-8 (Acetyl Octapeptide-3) is a synthetic peptide that functions as a SNAP-25 analog, competing with native SNAP-25 in the SNARE complex assembly required for synaptic vesicle fusion and acetylcholine release at neuromuscular junctions. By reducing acetylcholine release in facial expression muscles, SNAP-8 produces relaxation of expression lines through a mechanism conceptually similar to botulinum toxin, but applied topically rather than by injection.[1]
SNAP-8 is exclusively a TOPICAL cosmetic ingredient -it is NOT injectable. It is formulated at 5–10% concentration in cosmetic vehicles and applied 1–2 times daily to target areas. Effects are more gradual and subtle than injectable neurotoxins but avoid the risks and costs of injection-based treatments.
Observed Effects & Side Effect Profile
The following observations are derived from preclinical literature and limited early-phase human data. They do not constitute clinical claims.
- Non-invasive topical alternative to injectable neurotoxins
- Reduces expression line depth through SNARE complex modulation
- No injection required -applied as cosmetic cream/serum
- Well-tolerated topical ingredient with established cosmetic use
- Effects are more gradual and subtle than botulinum toxin injections
- Topical penetration limits efficacy compared to injectable approaches
- Must be formulated properly in appropriate cosmetic vehicle
- Not FDA-approved as a drug -marketed as cosmetic ingredient
- Results vary significantly between individuals and formulations
Lifestyle Considerations
While the following suggestions are not protocol requirements, research on tissue repair and peptide efficacy consistently highlights these as factors that influence outcomes:
Important Notes
References
All dosing recommendations and mechanism descriptions on this page are derived from the following peer-reviewed publications and regulatory documents.